Literature DB >> 8547593

Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes.

S Regunathan1, D L Feinstein, W Raasch, D J Reis.   

Abstract

We investigated whether astrocytes store and synthesize agmatine (decarboxylated arginine), an endogenous ligand for imidazoline and alpha 2-adrenergic receptors, in brain. Agmatine, detected chemically and immunocytochemically, is contained in cultured astrocytes and C6 glioma cells (8.5 +/- 1.4 and 1.8 +/- 0.6 nmol mg-1 protein, respectively). Glial membranes express activity for arginine decarboxylase (ADC), the biosynthetic enzyme for agmatine (astrocytes 85.4 +/- 9.2; C6 cells 18.2 +/- 3.12 nmol h-1 mg-1 protein). Lipopolysaccharide, and inducer of glial nitric oxide synthase (iNOS), significantly reduced (C6) or did not affect (astrocytes) ADC activity. Inferferon-gamma, not affecting iNOS, elevated ADC activity in both cell types. Astrocytes are a site of synthesis and storage of agmatine. ADC and iNOS enzymes synthesizing distinct bioactive products from L-arginine, may be reciprocally regulated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547593     DOI: 10.1097/00001756-199510020-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Potential relevance of agmatine as a virulence factor of Helicobacter pylori.

Authors:  G J Molderings; M Burian; J Homann; M Nilius; M Göthert
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 3.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

4.  Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.

Authors:  A Casanovas; G Olmos; J Ribera; M A Boronat; J E Esquerda; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines.

Authors:  M Sastre; E Galea; D Feinstein; D J Reis; S Regunathan
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

6.  Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation.

Authors:  G J Molderings; S Menzel; M Kathmann; E Schlicker; M Göthert
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine.

Authors:  E Galea; S Regunathan; V Eliopoulos; D L Feinstein; D J Reis
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

8.  Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia.

Authors:  Che-Chuan Wang; Chung-Ching Chio; Ching-Hong Chang; Jinn-Rung Kuo; Ching-Ping Chang
Journal:  BMC Pharmacol       Date:  2010-09-06

9.  Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine.

Authors:  Meng-Yang Zhu; Abiye Iyo; John E Piletz; Soundar Regunathan
Journal:  Biochim Biophys Acta       Date:  2004-01-22

10.  Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain.

Authors:  Meng-Yang Zhu; Wei-Ping Wang; Zheng-Wei Cai; Soundar Regunathan; Gregory Ordway
Journal:  Eur J Neurosci       Date:  2008-03       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.